Net Loss of Brawn Biotech reported to Rs 0.61 crore in the quarter ended December 2023 as against net loss of Rs 0.04 crore during the previous quarter ended December 2022. Sales declined 54.99% to Rs 2.84 crore in the quarter ended December 2023 as against Rs 6.31 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales2.846.31 -55 OPM %-20.42-0.16 - PBDT-0.58-0.01 -5700 PBT-0.61-0.04 -1425 NP-0.61-0.04 -1425 Powered by Capital Market - Live News

Brawn Biotech will hold a meeting of the Board of Directors of the Company on 14 February 2024.Powered by Capital Market - Live News

Net Loss of Brawn Biotech reported to Rs 0.42 crore in the quarter ended September 2023 as against net loss of Rs 0.35 crore during the previous quarter ended September 2022. Sales declined 62.42% to Rs 2.92 crore in the quarter ended September 2023 as against Rs 7.77 crore during the previous quarter ended September 2022. ParticularsQuarter Ended�Sep. 2023Sep. 2022% Var. Sales2.927.77 -62 OPM %-13.36-4.38 - PBDT-0.39-0.34 -15 PBT-0.42-0.36 -17 NP-0.42-0.35 -20 Powered by Capital Market - Live News

Brawn Biotech will hold a meeting of the Board of Directors of the Company on 10 November 2023.Powered by Capital Market - Live News

Brawn Biotech announced that the 38th Annual General Meeting (AGM) of the company will be held on 25 September 2023.Powered by Capital Market - Live News